MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1

Published:2020-01-22 Issue:5 Volume:24 Page:3149-3156
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Jin Yang¹,Zhou Xu²,Yao Xiaoxiao¹,Zhang Zhuo³,Cui Manhua²,Lin Yang²^ORCID

Affiliation:

1. Jilin Provincial Key Laboratory on Molecular and Chemical Genetic The Second Hospital of Jilin University Changchun China

2. Department of Obstetrics and Gynecology The Second Hospital of Jilin University Changchun China

3. Department of Orthopedics China‐Japan Union Hospital of Jilin University Changchun China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14985

Reference28 articles.

1. Cancer statistics, 2017

2. Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors

3. Cervical cancer

4. MicroRNAs: small RNAs with a big role in gene regulation

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of NOB1 expression levels in various cancers: a systematic review and meta-analysis;Biomarkers in Medicine;2024-06-17

2. Retraction: MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1;Journal of Cellular and Molecular Medicine;2024-06

3. Lnc00113 promotes triple‐negative breast cancer progression via the NOB‐1/MAPK signaling axis;The Journal of Gene Medicine;2024-02

4. Aberrant DNA methylation signatures in gynecological malignancies;Epigenetics in Human Disease;2024

5. WTAP-mediated m 6 A modification of circSMOC1 accelerates the tumorigenesis of non-small cell lung cancer by regulating miR-612/CCL28 axis;2023-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3